Get Started

INTS

NASD Intensity Therapeutics, Inc.
Nov 4, 2026 · 2:01 PM ET DELAYED Market Open

$3.36 ↓ -0.02 (-0.59%) Trading Down from the previous close of $3.38, $0.14 below the day’s high of $3.50

YTD change
-67.24%
vs 20-day SMA
-0.57%
vs 200-day SMA
-34.82%

Price ranges

Previous day
$3.19 $3.40
open $3.39 close $3.38
-$0.01 (-0.29%)
Today
$3.30 $3.50
open $3.43 now $3.36
-$0.07 (-2.04%)
Past week
$3.14 $3.50
from $3.18 now $3.36
+$0.18 (+5.66%)
Past month
$3.00 $4.04
from $3.55 now $3.36
-$0.19 (-5.35%)
This year
$0.22 $10.26
from $10.26 now $3.36
-$6.90 (-67.24%)

Price & Performance

-1.82 (-35.00%) / 6M

$2.98$3.78$4.58$5.38May 4Aug 4Nov 3

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 98.8% away from all-time highs of $286.00
  • INTS is down 67% since the beginning of the year
  • INTS is down 75% over the past 12 months
  • INTS is down 5% over the past 1 month
  • 3% of all INTS investors are betting against INTS

INTS reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +531.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.11
Earnings momentum -12.6% Quarterly EPS growth
Quarterly change -12.6%

Valuation

P/E ratio N/A
Enterprise value $-285668.0
Beta 3.03

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$9.5M
Debt$95.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $11.0M

Intensity Therapeutics, Inc. is a clinical-stage biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.

Competitor comparison

TickerCompany PriceChange
CMXHF CSL Limited $139.16 +3.08%
ARGX argenx SE Sponsored ADR $901.12 +2.99%
ONC BeOne Medicines Ltd. Sponsored ADR $355.00 -1.74%
INCY Incyte Corporation $117.59 -2.04%
WXIBF Wuxi Biologics (Cayman) Inc. $5.54 -2.64%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.